NCT01407393View on ClinicalTrials.gov

Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Overweight and Obesity

Interventions

DEVICE

Glucosanol

2 tablets 3x daily for 12 weeks

DEVICE

Placebo

2 tablets 3x daily for 12 weeks

Trial Locations (1)

10709

Barbara Grube, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

InQpharm Group

INDUSTRY